Subscribe to RSS
DOI: 10.1055/s-0036-1579696
Cognitive Impairment in Multiple Sclerosis: Clinical Manifestation, Neuroimaging Correlates, and Treatment
Publication History
Publication Date:
26 April 2016 (online)
![](https://www.thieme-connect.de/media/sin/201602/lookinside/thumbnails/10-1055-s-0036-1579696_0067-1.jpg)
Abstract
Cognitive impairment is found in up to 70% of patients with multiple sclerosis (MS). Once thought of as a variant of subcortical dementia with a characteristic set of deficits, we now know that MS-related cognitive impairment can have many faces. This conceptual change in neuropsychology is embedded in a paradigm shift in the neuroscientific understanding of MS over the past 25 years: Partly based on modern neuroimaging techniques, the classical view of MS as an inflammatory demyelinating disease affecting the white matter of the central nervous system has been extended. In particular, many studies have shown that the MS pathology also includes neurodegeneration, and that gray matter structures such as the cerebral cortex can also show focal lesions, atrophy, or both. The authors present an updated summary of the clinical manifestation and neuroimaging correlates of cognitive impairment in MS, and discuss the relatively few treatment options available to date.
-
References
- 1 McDonald WI, Ron MA. Multiple sclerosis: the disease and its manifestations. Philos Trans R Soc Lond B Biol Sci 1999; 354 (1390) 1615-1622
- 2 Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci 2001; 22 (2) 117-139
- 3 Mitchell AJ, Benito-León J, González JM, Rivera-Navarro J. Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing. Lancet Neurol 2005; 4 (9) 556-566
- 4 Julian LJ, Vella L, Vollmer T, Hadjimichael O, Mohr DC. Employment in multiple sclerosis. Exiting and re-entering the work force. J Neurol 2008; 255 (9) 1354-1360
- 5 Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008; 7 (12) 1139-1151
- 6 Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000; 343 (13) 938-952
- 7 Kesselring J, Beer S. Symptomatic therapy and neurorehabilitation in multiple sclerosis. Lancet Neurol 2005; 4 (10) 643-652
- 8 Charcot JM. Lectures on the Diseases on the Nervous System Delivered at La Salpetrière. London: New Sydenham Society; 1877
- 9 Rao SM. Neuropsychology of multiple sclerosis: a critical review. J Clin Exp Neuropsychol 1986; 8 (5) 503-542
- 10 Jambor KL. Cognitive functioning in multiple sclerosis. Br J Psychiatry 1969; 115 (524) 765-775
- 11 Peyser JM, Edwards KR, Poser CM, Filskov SB. Cognitive function in patients with multiple sclerosis. Arch Neurol 1980; 37 (9) 577-579
- 12 Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991; 41 (5) 685-691
- 13 Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 1991; 41 (5) 692-696
- 14 Rao SM, St Aubin-Faubert P, Leo GJ. Information processing speed in patients with multiple sclerosis. J Clin Exp Neuropsychol 1989; 11 (4) 471-477
- 15 Lengenfelder J, Bryant D, Diamond BJ, Kalmar JH, Moore NB, DeLuca J. Processing speed interacts with working memory efficiency in multiple sclerosis. Arch Clin Neuropsychol 2006; 21 (3) 229-238
- 16 Rao SM, Grafman J, DiGiulio D , et al. Memory dysfunction in multiple sclerosis: its relation to working memory, semantic encoding, and implicit learning. Neuropsychology 1993; 7 (3) 364-374
- 17 DeLuca J, Gaudino EA, Diamond BJ, Christodoulou C, Engel RA. Acquisition and storage deficits in multiple sclerosis. J Clin Exp Neuropsychol 1998; 20 (3) 376-390
- 18 Beatty WW, Goodkin DE, Monson N, Beatty PA. Cognitive disturbances in patients with relapsing remitting multiple sclerosis. Arch Neurol 1989; 46 (10) 1113-1119
- 19 Drew M, Tippett LJ, Starkey NJ, Isler RB. Executive dysfunction and cognitive impairment in a large community-based sample with multiple sclerosis from New Zealand: a descriptive study. Arch Clin Neuropsychol 2008; 23 (1) 1-19
- 20 Benedict RH, Cookfair D, Gavett R , et al. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc 2006; 12 (4) 549-558
- 21 Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983; 33 (11) 1444-1452
- 22 Potagas C, Giogkaraki E, Koutsis G , et al. Cognitive impairment in different MS subtypes and clinically isolated syndromes. J Neurol Sci 2008; 267 (1–2) 100-106
- 23 Amato MP, Zipoli V, Portaccio E. Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J Neurol Sci 2006; 245 (1–2) 41-46
- 24 Achiron A, Barak Y. Cognitive impairment in probable multiple sclerosis. J Neurol Neurosurg Psychiatry 2003; 74 (4) 443-446
- 25 Glanz BI, Holland CM, Gauthier SA , et al. Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. Mult Scler 2007; 13 (8) 1004-1010
- 26 Achiron A, Polliack M, Rao SM , et al. Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves. J Neurol Neurosurg Psychiatry 2005; 76 (5) 744-749
- 27 Sumowski JF, Chiaravalloti N, DeLuca J. Cognitive reserve protects against cognitive dysfunction in multiple sclerosis. J Clin Exp Neuropsychol 2009; 31 (8) 913-926
- 28 Cummings JL, Benson DF. Subcortical dementia. Review of an emerging concept. Arch Neurol 1984; 41 (8) 874-879
- 29 Bonelli RM, Cummings JL. Frontal-subcortical dementias. Neurologist 2008; 14 (2) 100-107
- 30 Calabrese P, Penner IK. Cognitive dysfunctions in multiple sclerosis—a “multiple disconnection syndrome”?. J Neurol 2007; 254 (Suppl. 02) II18-II21
- 31 DeLuca J, Barbieri-Berger S, Johnson SK. The nature of memory impairments in multiple sclerosis: acquisition versus retrieval. J Clin Exp Neuropsychol 1994; 16 (2) 183-189
- 32 Thornton AE, Raz N. Memory impairment in multiple sclerosis: a quantitative review. Neuropsychology 1997; 11 (3) 357-366
- 33 Lengenfelder J, Chiaravalloti ND, Ricker JH, DeLuca J. Deciphering components of impaired working memory in multiple sclerosis. Cogn Behav Neurol 2003; 16 (1) 28-39
- 34 Zarei M, Chandran S, Compston A, Hodges J. Cognitive presentation of multiple sclerosis: evidence for a cortical variant. J Neurol Neurosurg Psychiatry 2003; 74 (7) 872-877
- 35 Puthenparampil M, Poggiali D, Causin F , et al. Cortical relapses in multiple sclerosis. Mult Scler 2015; ; In press
- 36 Kamm CP, Heldner MR, Vanbellingen T, Mattle HP, Müri R, Bohlhalter S. Limb apraxia in multiple sclerosis: prevalence and impact on manual dexterity and activities of daily living. Arch Phys Med Rehabil 2012; 93 (6) 1081-1085
- 37 Rocca MA, Amato MP, De Stefano N , et al; MAGNIMS Study Group. Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. Lancet Neurol 2015; 14 (3) 302-317
- 38 Kesselring J, Klement U. Cognitive and affective disturbances in multiple sclerosis. J Neurol 2001; 248 (3) 180-183
- 39 Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry 2005; 76 (4) 469-475
- 40 Arnett PA, Barwick FH, Beeney JE. Depression in multiple sclerosis: review and theoretical proposal. J Int Neuropsychol Soc 2008; 14 (5) 691-724
- 41 Arnett PA, Higginson CI, Voss WD , et al. Depressed mood in multiple sclerosis: relationship to capacity-demanding memory and attentional functioning. Neuropsychology 1999; 13 (3) 434-446
- 42 Landrø NI, Celius EG, Sletvold H. Depressive symptoms account for deficient information processing speed but not for impaired working memory in early phase multiple sclerosis (MS). J Neurol Sci 2004; 217 (2) 211-216
- 43 Niino M, Mifune N, Kohriyama T , et al. Apathy/depression, but not subjective fatigue, is related with cognitive dysfunction in patients with multiple sclerosis. BMC Neurol 2014; 14: 3
- 44 Krupp L. Fatigue is intrinsic to multiple sclerosis (MS) and is the most commonly reported symptom of the disease. Mult Scler 2006; 12 (4) 367-368
- 45 Minden SL, Frankel D, Hadden L, Perloffp J, Srinath KP, Hoaglin DC. The Sonya Slifka Longitudinal Multiple Sclerosis Study: methods and sample characteristics. Mult Scler 2006; 12 (1) 24-38
- 46 Hadjimichael O, Vollmer T, Oleen-Burkey M ; North American Research Committee on Multiple Sclerosis. Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey. Health Qual Life Outcomes 2008; 6: 100
- 47 Penner I, Calabrese P. Managing fatigue: clinical correlates, assessment procedures and therapeutic strategies. Int MS J 2010; 17 (1) 28-34
- 48 Schwid SR, Tyler CM, Scheid EA, Weinstein A, Goodman AD, McDermott MP. Cognitive fatigue during a test requiring sustained attention: a pilot study. Mult Scler 2003; 9 (5) 503-508
- 49 Diamond BJ, Johnson SK, Kaufman M, Graves L. Relationships between information processing, depression, fatigue and cognition in multiple sclerosis. Arch Clin Neuropsychol 2008; 23 (2) 189-199
- 50 Neumann M, Sterr A, Claros-Salinas D, Gütler R, Ulrich R, Dettmers C. Modulation of alertness by sustained cognitive demand in MS as surrogate measure of fatigue and fatigability. J Neurol Sci 2014; 340 (1–2) 178-182
- 51 Morrow SA, Weinstock-Guttman B, Munschauer FE, Hojnacki D, Benedict RH. Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis. Mult Scler 2009; 15 (8) 998-1005
- 52 Fox RJ. Picturing multiple sclerosis: conventional and diffusion tensor imaging. Semin Neurol 2008; 28 (4) 453-466
- 53 Barkhof F. The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 2002; 15 (3) 239-245
- 54 McDonald WI, Compston A, Edan G , et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001; 50 (1) 121-127
- 55 Bakshi R, Thompson AJ, Rocca MA , et al. MRI in multiple sclerosis: current status and future prospects. Lancet Neurol 2008; 7 (7) 615-625
- 56 Charil A, Yousry TA, Rovaris M , et al. MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation”. Lancet Neurol 2006; 5 (10) 841-852
- 57 Barkhof F, van Walderveen M. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance. Philos Trans R Soc Lond B Biol Sci 1999; 354 (1390) 1675-1686
- 58 Miller DH, Grossman RI, Reingold SC, McFarland HF. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998; 121 (Pt 1): 3-24
- 59 Rao SM. White matter disease and dementia. Brain Cogn 1996; 31 (2) 250-268
- 60 Brownell B, Hughes JT. The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 1962; 25: 315-320
- 61 Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. Cortical lesions in multiple sclerosis. Brain 1999; 122 (Pt 1): 17-26
- 62 Bakshi R, Ariyaratana S, Benedict RH, Jacobs L. Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions. Arch Neurol 2001; 58 (5) 742-748
- 63 Geurts JJ, Pouwels PJ, Uitdehaag BM, Polman CH, Barkhof F, Castelijns JA. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 2005; 236 (1) 254-260
- 64 Sanfilipo MP, Benedict RH, Weinstock-Guttman B, Bakshi R. Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis. Neurology 2006; 66 (5) 685-692
- 65 Pelletier J, Suchet L, Witjas T , et al. A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis. Arch Neurol 2001; 58 (1) 105-111
- 66 Houtchens MK, Benedict RH, Killiany R , et al. Thalamic atrophy and cognition in multiple sclerosis. Neurology 2007; 69 (12) 1213-1223
- 67 Bermel RA, Innus MD, Tjoa CW, Bakshi R. Selective caudate atrophy in multiple sclerosis: a 3D MRI parcellation study. Neuroreport 2003; 14 (3) 335-339
- 68 Sicotte NL, Kern KC, Giesser BS , et al. Regional hippocampal atrophy in multiple sclerosis. Brain 2008; 131 (Pt 4): 1134-1141
- 69 Sailer M, Fischl B, Salat D , et al. Focal thinning of the cerebral cortex in multiple sclerosis. Brain 2003; 126 (Pt 8): 1734-1744
- 70 Parisi L, Rocca MA, Mattioli F , et al. Patterns of regional gray matter and white matter atrophy in cortical multiple sclerosis. J Neurol 2014; 261 (9) 1715-1725
- 71 Bermel RA, Bakshi R. The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 2006; 5 (2) 158-170
- 72 Giorgio A, Stromillo ML, Rossi F , et al. Cortical lesions in radiologically isolated syndrome. Neurology 2011; 77 (21) 1896-1899
- 73 Calabrese M, Magliozzi R, Ciccarelli O, Geurts JJ, Reynolds R, Martin R. Exploring the origins of grey matter damage in multiple sclerosis. Nat Rev Neurosci 2015; 16 (3) 147-158
- 74 Franklin GM, Heaton RK, Nelson LM, Filley CM, Seibert C. Correlation of neuropsychological and MRI findings in chronic/progressive multiple sclerosis. Neurology 1988; 38 (12) 1826-1829
- 75 Rao SM, Leo GJ, Haughton VM, St Aubin-Faubert P, Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 1989; 39 (2 Pt 1): 161-166
- 76 Lazeron RH, Boringa JB, Schouten M , et al. Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis. Mult Scler 2005; 11 (5) 524-531
- 77 Benedict RH, Bruce J, Dwyer MG , et al. Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis. Mult Scler 2007; 13 (6) 722-730
- 78 Patti F, Amato MP, Trojano M , et al; COGIMUS Study Group. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Mult Scler 2009; 15 (7) 779-788
- 79 Sperling RA, Guttmann CR, Hohol MJ , et al. Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study. Arch Neurol 2001; 58 (1) 115-121
- 80 Archibald CJ, Wei X, Scott JN , et al. Posterior fossa lesion volume and slowed information processing in multiple sclerosis. Brain 2004; 127 (Pt 7): 1526-1534
- 81 Reuter F, Zaaraoui W, Crespy L , et al. Cognitive impairment at the onset of multiple sclerosis: relationship to lesion location. Mult Scler 2011; 17 (6) 755-758
- 82 Seewann A, Kooi EJ, Roosendaal SD , et al. Postmortem verification of MS cortical lesion detection with 3D DIR. Neurology 2012; 78 (5) 302-308
- 83 Calabrese M, Agosta F, Rinaldi F , et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 2009; 66 (9) 1144-1150
- 84 Calabrese M, Poretto V, Favaretto A , et al. Cortical lesion load associates with progression of disability in multiple sclerosis. Brain 2012; 135 (Pt 10): 2952-2961
- 85 Roosendaal SD, Moraal B, Pouwels PJ , et al. Accumulation of cortical lesions in MS: relation with cognitive impairment. Mult Scler 2009; 15 (6) 708-714
- 86 Geisseler O, Pflugshaupt T, Bezzola L , et al. MS-Cortex study: the contribution of cortical lesions to cognitive impairment in patients with multiple sclerosis. Paper presented at: MSBOSTON 2014; September 11, 2014; Boston, MA
- 87 Zivadinov R, Sepcic J, Nasuelli D , et al. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2001; 70 (6) 773-780
- 88 Benedict RH, Weinstock-Guttman B, Fishman I, Sharma J, Tjoa CW, Bakshi R. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol 2004; 61 (2) 226-230
- 89 Benedict RH, Bruce JM, Dwyer MG , et al. Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. Arch Neurol 2006; 63 (9) 1301-1306
- 90 Tiemann L, Penner IK, Haupts M, Schlegel U, Calabrese P. Cognitive decline in multiple sclerosis: impact of topographic lesion distribution on differential cognitive deficit patterns. Mult Scler 2009; 15 (10) 1164-1174
- 91 Tekok-Kilic A, Benedict RH, Weinstock-Guttman B , et al. Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis. Neuroimage 2007; 36 (4) 1294-1300
- 92 Deluca J, Leavitt VM, Chiaravalloti N, Wylie G. Memory impairment in multiple sclerosis is due to a core deficit in initial learning. J Neurol 2013; 260 (10) 2491-2496
- 93 Radomski AD, Power C, Purdon SE , et al. Decision-making under explicit risk is impaired in multiple sclerosis: relationships with ventricular width and disease disability. BMC Neurol 2015; 15: 61
- 94 Mike A, Strammer E, Aradi M , et al. Disconnection mechanism and regional cortical atrophy contribute to impaired processing of facial expressions and theory of mind in multiple sclerosis: a structural MRI study. PLoS ONE 2013; 8 (12) e82422
- 95 Geisseler O, Pflugshaupt T, Bezzola L , et al. Cortical thinning in the anterior cingulate cortex predicts multiple sclerosis patients' fluency performance in a lateralised manner. NeuroImage Clin 2016; 10: 89-95
- 96 Robinson G, Shallice T, Bozzali M, Cipolotti L. The differing roles of the frontal cortex in fluency tests. Brain 2012; 135 (Pt 7): 2202-2214
- 97 Patti F, Leone C, D'Amico E. Treatment options of cognitive impairment in multiple sclerosis. Neurol Sci 2010; 31 (Suppl. 02) S265-S269
- 98 Fischer JS, Priore RL, Jacobs LD , et al; Multiple Sclerosis Collaborative Research Group. Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Ann Neurol 2000; 48 (6) 885-892
- 99 Patti F, Amato MP, Bastianello S , et al; COGIMUS Study Group. Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis. Mult Scler 2010; 16 (1) 68-77
- 100 Patti F, Morra VB, Amato MP , et al; COGIMUS Study Group. Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study. PLoS ONE 2013; 8 (8) e74111
- 101 Kappos L, Freedman MS, Polman CH , et al; BENEFIT Study Group. Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. Lancet Neurol 2009; 8 (11) 987-997
- 102 Edan G, Kappos L, Montalbán X , et al; BENEFIT Study Group. Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT. J Neurol Neurosurg Psychiatry 2014; 85 (11) 1183-1189
- 103 Weinstock-Guttman B, Galetta SL, Giovannoni G , et al. Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS. J Neurol 2012; 259 (5) 898-905
- 104 Amato MP, Langdon D, Montalban X , et al. Treatment of cognitive impairment in multiple sclerosis: position paper. J Neurol 2013; 260 (6) 1452-1468
- 105 Lange R, Volkmer M, Heesen C, Liepert J. Modafinil effects in multiple sclerosis patients with fatigue. J Neurol 2009; 256 (4) 645-650
- 106 Geisler MW, Sliwinski M, Coyle PK, Masur DM, Doscher C, Krupp LB. The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis. Arch Neurol 1996; 53 (2) 185-188
- 107 Harel Y, Appleboim N, Lavie M, Achiron A. Single dose of methylphenidate improves cognitive performance in multiple sclerosis patients with impaired attention process. J Neurol Sci 2009; 276 (1–2) 38-40
- 108 Krupp LB, Christodoulou C, Melville P , et al. Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis. Neurology 2011; 76 (17) 1500-1507
- 109 Shaygannejad V, Janghorbani M, Ashtari F, Zanjani HA, Zakizade N. Effects of rivastigmine on memory and cognition in multiple sclerosis. Can J Neurol Sci 2008; 35 (4) 476-481
- 110 Lovera JF, Frohman E, Brown TR , et al. Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial. Mult Scler 2010; 16 (6) 715-723
- 111 Sumowski JF, Chiaravalloti N, Erlanger D, Kaushik T, Benedict RH, DeLuca J. L-amphetamine improves memory in MS patients with objective memory impairment. Mult Scler 2011; 17 (9) 1141-1145
- 112 Smits RC, Emmen HH, Bertelsmann FW, Kulig BM, van Loenen AC, Polman CH. The effects of 4-aminopyridine on cognitive function in patients with multiple sclerosis: a pilot study. Neurology 1994; 44 (9) 1701-1705
- 113 Lovera J, Bagert B, Smoot K , et al. Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo-controlled trial. Mult Scler 2007; 13 (3) 376-385
- 114 Patti F. Treatment of cognitive impairment in patients with multiple sclerosis. Expert Opin Investig Drugs 2012; 21 (11) 1679-1699
- 115 Lovera J, Kovner B. Cognitive impairment in multiple sclerosis. Curr Neurol Neurosci Rep 2012; 12 (5) 618-627
- 116 Filippi M, Rocca MA. Let's rehabilitate cognitive rehabilitation in multiple sclerosis. Neurology 2013; 81 (24) 2060-2061
- 117 das Nair R, Ferguson H, Stark DL, Lincoln NB. Memory rehabilitation for people with multiple sclerosis. Cochrane Database Syst Rev 2012; 3: CD008754
- 118 Rosti-Otajärvi EM, Hämäläinen PI. Neuropsychological rehabilitation for multiple sclerosis. Cochrane Database Syst Rev 2014; 2: CD009131
- 119 Mendozzi L, Pugnetti L, Motta A, Barbieri E, Gambini A, Cazzullo CL. Computer-assisted memory retraining of patients with multiple sclerosis. Ital J Neurol Sci 1998; 19 (6) 431-438
- 120 Solari A, Motta A, Mendozzi L , et al; CRIMS Trial. Computer-aided retraining of memory and attention in people with multiple sclerosis: a randomized, double-blind controlled trial. J Neurol Sci 2004; 222 (1–2) 99-104
- 121 Vogt A, Kappos L, Stöcklin M, Gschwind L, Opwis K, Penner IK. BrainStim-Wirksamkeit eines neu entwickelten kognitiven Trainingsprogramms bei MS. Neurol Rehabil 2008; 14 (2) 93-101
- 122 Shatil E, Metzer A, Horvitz O, Miller A. Home-based personalized cognitive training in MS patients: a study of adherence and cognitive performance. NeuroRehabilitation 2010; 26 (2) 143-153
- 123 Mattioli F, Stampatori C, Zanotti D, Parrinello G, Capra R. Efficacy and specificity of intensive cognitive rehabilitation of attention and executive functions in multiple sclerosis. J Neurol Sci 2010; 288 (1–2) 101-105
- 124 Cerasa A, Gioia MC, Valentino P , et al. Computer-assisted cognitive rehabilitation of attention deficits for multiple sclerosis: a randomized trial with fMRI correlates. Neurorehabil Neural Repair 2013; 27 (4) 284-295
- 125 Lincoln NB, Dent A, Harding J , et al. Evaluation of cognitive assessment and cognitive intervention for people with multiple sclerosis. J Neurol Neurosurg Psychiatry 2002; 72 (1) 93-98
- 126 Tesar N, Bandion K, Baumhackl U. Efficacy of a neuropsychological training programme for patients with multiple sclerosis — a randomised controlled trial. Wien Klin Wochenschr 2005; 117 (21–22) 747-754
- 127 Chiaravalloti ND, DeLuca J, Moore NB, Ricker JH. Treating learning impairments improves memory performance in multiple sclerosis: a randomized clinical trial. Mult Scler 2005; 11 (1) 58-68
- 128 Hildebrandt H, Lanz M, Hahn HK , et al. Cognitive training in MS: effects and relation to brain atrophy. Restor Neurol Neurosci 2007; 25 (1) 33-43
- 129 Fink F, Rischkau E, Butt M, Klein J, Eling P, Hildebrandt H. Efficacy of an executive function intervention programme in MS: a placebo-controlled and pseudo-randomized trial. Mult Scler 2010; 16 (9) 1148-1151
- 130 Brissart H, Leroy M, Morele E, Baumann C, Spitz E, Debouverie M. Cognitive rehabilitation in multiple sclerosis. Neurocase 2013; 19 (6) 553-565
- 131 Stuifbergen AK, Becker H, Perez F, Morison J, Kullberg V, Todd A. A randomized controlled trial of a cognitive rehabilitation intervention for persons with multiple sclerosis. Clin Rehabil 2012; 26 (10) 882-893
- 132 Plohmann AM, Kappos L, Ammann W , et al. Computer assisted retraining of attentional impairments in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 1998; 64 (4) 455-462
- 133 Mattioli F, Stampatori C, Bellomi F , et al. A RCT comparing specific intensive cognitive training to aspecific psychological intervention in RRMS: the SMICT study. Front Neurol 2014; 5: 278
- 134 Chiaravalloti ND, Moore NB, Nikelshpur OM, DeLuca J. An RCT to treat learning impairment in multiple sclerosis: the MEMREHAB trial. Neurology 2013; 81 (24) 2066-2072
- 135 Chiaravalloti ND, DeLuca J. The influence of cognitive dysfunction on benefit from learning and memory rehabilitation in MS: a sub-analysis of the MEMREHAB trial. Mult Scler 2015; 21 (12) 1575-1582
- 136 Cicerone KD, Langenbahn DM, Braden C , et al. Evidence-based cognitive rehabilitation: updated review of the literature from 2003 through 2008. Arch Phys Med Rehabil 2011; 92 (4) 519-530
- 137 Rees L, Marshall S, Hartridge C, Mackie D, Weiser M ; Erabi Group. Cognitive interventions post acquired brain injury. Brain Inj 2007; 21 (2) 161-200
- 138 Sandroff BM, Klaren RE, Pilutti LA, Dlugonski D, Benedict RH, Motl RW. Randomized controlled trial of physical activity, cognition, and walking in multiple sclerosis. J Neurol 2014; 261 (2) 363-372
- 139 Sandroff BM, Hillman CH, Benedict RH, Motl RW. Acute effects of walking, cycling, and yoga exercise on cognition in persons with relapsing-remitting multiple sclerosis without impaired cognitive processing speed. J Clin Exp Neuropsychol 2015; 37 (2) 209-219
- 140 Beier M, Bombardier CH, Hartoonian N, Motl RW, Kraft GH. Improved physical fitness correlates with improved cognition in multiple sclerosis. Arch Phys Med Rehabil 2014; 95 (7) 1328-1334
- 141 Motl RW, Sandroff BM, Benedict RH. Cognitive dysfunction and multiple sclerosis: developing a rationale for considering the efficacy of exercise training. Mult Scler 2011; 17 (9) 1034-1040
- 142 Dagenais E, Rouleau I, Demers M , et al. Value of the MoCA test as a screening instrument in multiple sclerosis. Can J Neurol Sci 2013; 40 (3) 410-415